NCT05477277Recruiting
Adverse Outcomes and Mortality in Liver Transplant
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 12 Jul 2022
- Start date
- 2 Nov 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Mayo Clinic
- Diseases
- Obesity
- NCT number
- NCT05477277
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 2 Nov 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Contra indication to MRI
Who the study is looking for
- All patients with end-stage liver disease undergoing evaluation for liver transplantation
- Patient clinically indicated for MRI during transplant candidacy evaluation
- Adult
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic - Arizona Coordinator of this site? Confirm its status | Phoenix | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.